Compare Kromek Group Plc with Similar Stocks
Dashboard
1
With a growth in Net Sales of 30.81%, the company declared Outstanding results in Oct 25
- NET SALES(Q) At GBP 15.01 MM has Grown at 308.41%
- OPERATING CASH FLOW(Y) Highest at GBP 14.93 MM
- ROCE(HY) Highest at 25.05%
2
With ROE of 21.98%, it has a very attractive valuation with a 1.30 Price to Book Value
3
Market Beating Performance
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
14.71%
0%
14.71%
6 Months
62.5%
0%
62.5%
1 Year
66.67%
0%
66.67%
2 Years
66.67%
0%
66.67%
3 Years
25.81%
0%
25.81%
4 Years
-13.33%
0%
-13.33%
5 Years
-39.96%
0%
-39.96%
Kromek Group Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
25.08%
EBIT Growth (5y)
33.99%
EBIT to Interest (avg)
-5.04
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.28
Sales to Capital Employed (avg)
0.33
Tax Ratio
3.73%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
1.30
EV to EBIT
5.81
EV to EBITDA
4.27
EV to Capital Employed
1.29
EV to Sales
1.95
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
22.30%
ROE (Latest)
21.98%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Apr'25
Apr'25
Apr'24
Change(%)
Net Sales
26.50
19.40
36.60%
Operating Profit (PBDIT) excl Other Income
9.30
2.60
257.69%
Interest
1.80
1.90
-5.26%
Exceptional Items
0.00
0.30
-100.00%
Consolidate Net Profit
3.80
-3.30
215.15%
Operating Profit Margin (Excl OI)
177.40%
-98.90%
27.63%
USD in Million.
Net Sales
YoY Growth in year ended Apr 2025 is 36.60% vs 12.14% in Apr 2024
Consolidated Net Profit
YoY Growth in year ended Apr 2025 is 215.15% vs 45.90% in Apr 2024
About Kromek Group Plc 
Kromek Group Plc
Pharmaceuticals & Biotechnology
Kromek Group plc is a radiation detection technology company. The Company develops radiation detectors based on cadmium zinc telluride. The Company's segments are UK Operations and US Operations. The Company designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets. The Company's solutions provide information on material composition and structure to enable the identification of cancerous tissues and hazardous materials (including explosives), and the analysis of radioactive materials. Its nuclear products include CPG, GR1-Gamma Ray Spectrometer, GR1A, SIGMA, TN15, RayMon10, Quant Air and RENA-Mini Development Platform. It offers detectors and subcomponents for original equipment manufacturer (OEM) customers in the medical imaging market, including computed tomography (CT), single photon emission computed tomography (SPECT), positron emission tomography (PET) and bone mineral densitometry.
Company Coordinates 
Company Details
Netpark Incubator, Thomas Wright Way , STOCKTON-ON-TEES None : TS21 3FD
Registrar Details






